Osaic Holdings’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $25.1M | Buy |
328,111
+70,299
| +27% | +$5.38M | 0.06% | 341 |
|
2025
Q1 | $17.9M | Buy |
257,812
+17,148
| +7% | +$1.19M | 0.04% | 450 |
|
2024
Q4 | $20.7M | Sell |
240,664
-65,914
| -21% | -$5.67M | 0.05% | 389 |
|
2024
Q3 | $36.5M | Sell |
306,578
-69,340
| -18% | -$8.26M | 0.08% | 241 |
|
2024
Q2 | $53.7M | Buy |
375,918
+12,080
| +3% | +$1.73M | 0.13% | 158 |
|
2024
Q1 | $46.7M | Sell |
363,838
-174,270
| -32% | -$22.4M | 0.1% | 193 |
|
2023
Q4 | $55.7M | Sell |
538,108
-106,767
| -17% | -$11M | 0.1% | 195 |
|
2023
Q3 | $58.7M | Buy |
644,875
+226,013
| +54% | +$20.6M | 0.09% | 211 |
|
2023
Q2 | $33.8M | Buy |
418,862
+42,842
| +11% | +$3.46M | 0.06% | 287 |
|
2023
Q1 | $29.9M | Buy |
376,020
+33,364
| +10% | +$2.66M | 0.06% | 319 |
|
2022
Q4 | $23.2M | Buy |
342,656
+2,552
| +0.8% | +$173K | 0.05% | 387 |
|
2022
Q3 | $16.9M | Buy |
340,104
+7,618
| +2% | +$380K | 0.04% | 438 |
|
2022
Q2 | $18.5M | Buy |
332,486
+86,146
| +35% | +$4.8M | 0.04% | 409 |
|
2022
Q1 | $12.3M | Buy |
246,340
+48,218
| +24% | +$2.41M | 0.02% | 647 |
|
2021
Q4 | $11.1M | Buy |
198,122
+19,988
| +11% | +$1.12M | 0.02% | 689 |
|
2021
Q3 | $8.55M | Buy |
178,134
+11,476
| +7% | +$551K | 0.02% | 743 |
|
2021
Q2 | $6.99M | Buy |
166,658
+16,918
| +11% | +$710K | 0.02% | 842 |
|
2021
Q1 | $5.05M | Buy |
149,740
+4,954
| +3% | +$167K | 0.01% | 963 |
|
2020
Q4 | $5.06M | Sell |
144,786
-344
| -0.2% | -$12K | 0.01% | 861 |
|
2020
Q3 | $5M | Sell |
145,130
-13,488
| -9% | -$465K | 0.02% | 757 |
|
2020
Q2 | $5.19M | Sell |
158,618
-37,846
| -19% | -$1.24M | 0.02% | 676 |
|
2020
Q1 | $4.79M | Buy |
+196,464
| New | +$4.79M | 0.02% | 628 |
|